miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery.

Xiqi PengXiang PanKaihao LiuChunduo ZhangLiwen ZhaoHang LiXin GuanWeijie XuJinling XuFangting ZhangYongqing Lai

Published in: The International journal of biological markers (2019)

Our results suggest miR-142-3p expression is correlated with poor prognosis of renal cell carcinoma patients and may serve as a prognostic biomarker in the future.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
renal cell carcinoma
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
current status